[1] National Health Comission of the People’s Republic of China. Notice on novel coronavirus pneumonia diagnosis and treatment plan (trial version 7). (2020). http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe-4cef80dc7f5912eb1989.shtml [Accessed March 9, 2020].
[2] Hu Q. J., Guan, H. X., Sun, Z. Y., Huang, L., Chen, C., Ai, T., et al. (2020). Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan, China. Eur J Radiol, 128(undefined), 109017. doi:10.1016/j.ejrad.2020.109017
[3] Liu, X. J., Qu, J. J., Yang, X., and XUE, Y.W. (2020). The characteristics of CT imaging of novel coronavirus pneumonia. Journal of Heze Medical College, 32(01):12-16. doi: 10.3969/j.issn.1008-4118.2020.01.004
[4] Shi, S. B., Qin, M., Shen, B., Cai, Y. L., Liu, T., Yang, F., et al. (2020). Association of Cardiac Injury with Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol, undefined (undefined), undefined. doi: 10.1001/jamacardio.2020.0950
[5] Wei, J. F., Huang, F. Y., Xiong, T. Y., Liu, Q., Chen, H., Wang, H., et al. (2020). Acute myocardial injury is common in patients with covid-19 and impairs their prognosis. Heart, undefined (undefined), undefined. doi: 10.1136/heartjnl-2020-317007
[6] Dong, N. G., Cai, J., Zhou, Y., Liu, J. W., and Li, F. (2020). End-Stage Heart Failure With COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV. JACC Heart Fail, 8(6), 515-517. doi: 10.1016/j.jchf.2020.04.001
[7] Xu, X. T., Chen, P., Wang, J. F., Feng, J. N., Zhou, H., Li. X., et al. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci, 63(3), 457-460. doi: 10.1007/s11427-020-1637-5
[8] Zhang, X. Q., Li, S. R., Niu, and S. Q. (2020). ACE2 and novel coronavirus pneumonia. International Journal of Cardiovascular Disease, 47(02):68-70. doi: 10.3969/j.issn.1673-6583.2020.02.002
[9] He, Y. J., Song, B. Q., Yang, L. Y., Zhang, Y. L., and Liu, W. A. (2020). Discussion on Scientific Basis of Acupuncture Prevention and Treatment of Novel Coronavirus Pneumonia from “Inflammatory Storm” Theory. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology: 1-4. doi: 10.11842/wst.20200228002
[10] Gong, X.Y., Wei, D. R., Gong, X., Xiong, Y., Wang, T., and Mou, F. Z. (2020). Analysis on TCM Clinical Characteristics and Syndromes of 80 Patients with Novel Coronavirus Pneumonia. Chinese Journal of Information on Traditional Chinese Medicine: 1-6. doi: 10.3969/j.issn.1005-5304.202002560
[11] Qu, Y. F., Fang, W., Jin Y. Z., Qin, C., Niu, X.C., Zhang, N., et al. (2020). Forty Cases of Common COVID-19 Treated with Modified Ephedra and Apricot Kernel and Gypsum and Licorice Decoction Combined with Western Medicine Routine Treatment. Henan Traditional Chinese Medicine, (05):666-669. doi: 10.16367/j.issn.1003-5028.2020.05.0167.
[12] Huang, X. J., Wei, G., Zhang, L., and Huang, K. W. (2014). Progress of pharmacological action and clinical application of Maxing Shigan tang. Journal of Guangdong Pharmaceutical University, 30(1):110-114. doi: 10.3969/j.issn.1006-8783.2014.01.025
[13] Jin, Y. H., Cai, L., Cheng, Z. S., Cheng, H., Deng, T., Fan, Y. P., et al. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Medical Journal of Chinese People's Liberation Army, 45(01): 1-20. doi: 10.11855/j.issn.0577-7402.2020.01.01
[14] National Health Comission of the People’s Republic of China. Notice on novel coronavirus pneumonia diagnosis and treatment plan (trial version 5). (2020). http://www.nhc.gov.cn/xcs/fkdt/202002/e84bd30142ab4d8982326326e4db22ea.shtml. [Accessed February 5, 2020].
[15] Shi, H, S., Han, X. Y., Fan, Y. Q., Liang, B., Yang, F., Han, P., et al. (2020). Radiologic Features of Patients with 2019-nCoV Infection. Journal of Clinical Radiology, 39(01):8-11. doi: 10.13437/j.cnki.jcr.20200206.002.
[16] Deng, W. H. (2013). Clinical application of Maxing Shigan Decoction. Chinese Journal of Clinical Rational Drug Use, 6(16): 180-181. doi: 10.15887/j.cnki.13-1389/r.2013.16.022
[17] Lin, Z. C., Wu, X. P., and Lin, S. Y. (2018). The effect of Jiawei Maxing Shigan Decoction on the regulation of transforming growth factor β/Smad signal pathway in radiation-induced pulmonary fibrosis. Chinese Journal of Critical Care Medicine(Electronic Edition), 11(06): 403-406. doi: 10.3877/cma.j.issn.1674-6880.2018.06.009
[18] Peng, X. F., Shi, X. G., Xu, Y. Y., Huang, Z. J.,and Wang, W. G. (2008). Effect of Maxing Ganshi Decoction on cytokines related to acute lung injury in rats. Journal of Chinese Medicinal Materials, (05): 739-740. doi: 10.13863/j.issn1001-4454.2008.05.042
[19] Zhong, Y., Zhou, J., Liang, N., Liu, B., Lu, R., He, Y., et al. (2016). Effect of Maxing Shigan Tang on H1N1 Influenza A Virus-Associated Acute Lung Injury in Mice. Intervirology, 59(5-6), 267-274. doi: 10.1159/000458726
[20] Li, L., Wei, K., Lu, F. G., Cai, L., Zhang, B., Zhang, S. Y. et al. (2017). Effect of Maxing Shigan Decoction against type A influenza virus infection in mice induced by viral lung injury based on TLR4-MyD88-TRAF6 signal pathways. Chinese Traditional and Herbal Drugs, 48(08): 1591-1596. doi: 10.7501/j.issn.0253-2670.2017.08.017
[21] Zhang, S. Y., He, G. L., Lu, F.G., Li, L., Zhang, B., Dai, B., et al. (2019). Mechanism research of anti influenza virus of ephedra decocted earlier Maxing Shigan Decoction from the expression level of IFN-α/β protein mediated by TLR7/8. China Journal of Traditional Chinese Medicine and Pharmacy, 34 (3): 1188-1193.
[22] Li, L., Wu J. M., Ouyang, J. J., Hu, J., Liao, C., Yuan, P., et al. (2018). Study on screening and mechanism of effective Chinese medicine for influenza virus pneumonia. Chinese Journal of Immunology, 34 (8): 1168-1173. doi: 10.3969/j.issn.1000-484X.2018.08.009
[23] Kaur, S., Bansal, Y., Kumar, R., and Bansal, G. (2020). A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors. Bioorg. Med. Chem., 28(5), 115327. doi: 10.1016/j.bmc.2020.115327
[24] Chen, X. H., He, Y. C., Zhou, Y. P.,Chun, Y. T., Huang, Y. S., Yao, C. N., et al. (2001). The relationship between TGF-β 1, TNF-α and IL-6 with liver fibrosis. Shanghai J.of Immunology, 21(6): 364-365. doi: 10.3969/j.issn.1001-2478.2001.06.016.
[25] Panteva, M., Korkaya, H., and Jameel, S. (2003). Hepatitis viruses and the MAPK pathway: is this a survival strategy? Virus Research, 92(2), 131–140. doi: 10.1016/s0168-1702(02)00356-8
[26] Zhao, Y., Yang, J. H., Han, J. P., Li, S., Yu, Y. Y., Fan, Z. Z., et al. (2017). Research Progress of MEK/ERK Pathway in Bronchial Asthma Pathogenesis. Chinese Archives of Traditional Chinese Medicine, 35(2): 329-331. doi: 10.13193/j.issn.1673-7717.2017.02.020
[27] Li, T., and Zhang, X. J. (2019). Changes and significance of peripheral blood tumor necrosis factor-α, interleukin-10, platelet parameters and erythrocyte sedimentation rate in patients with sepsis and lung injury. Experimental and Laboratory Medicine, 37(06): 1083-1086. doi: 10.3969/j.issn.1674-1129.2019.06.030
[28] Tao, P., Xia, W. M., and Ai, T. (2019).Changes of serum VEGF, ET-1 and CK-MB in children with severe pneumonia and their relationship with myocardial damage. Journal of Clinical Pulmonary Medicine, 24(8): 1441-1445. doi: 10.3969/j.issn.1009-6663.2019.08.021
[29] Kurzepa, J., Kurzepa, J., Golab, P., Czerska, S., and Bielewicz, J. (2014). The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke. International Journal of Neuroscience, 124(10), 707–716. doi: 10.3109/00207454.2013.872102
[30] Yu, H., Pardoll, D., and Jove, R. (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Reviews Cancer, 9(11), 798–809. doi: 10.1038/nrc2734
[31] Yang, M. S., Zhou, N. Wang, Z. G., and Hao, H. F. (2016). Research Progress on the Role of Transcription Factor HIF-1α and Its Signal Pathway in the Pathogenesis. Biotechnology Bulletin, 32(08): 8-13. doi: 10.13560/j.cnki.biotech.bull.1985.2016.08.002
[32] Cai, X., Huang, Y., Zhang, X., Wang, S., Zou, Z., Wang, G., et al. (2014). Cloning, characterization, hypoxia and heat shock response of hypoxia inducible factor-1 (HIF-1) from the small abalone Haliotis diversicolor. Gene, 534(2), 256–264. doi: 10.1016/j.gene.2013.10.048
[33] Pan, Y. D., Pan, X. D., Li, J., Chen, R., and Han, Z. (2020). Detection of inflammatory factors secondary to pulmonary infection and analysis of the role of TLR7/IL-23/IL-17 signaling pathway in chronic obstructive pulmonary disease. Chinese Journal of Nosocomiology, (07): 994-998. doi: 10.11816/cn.ni.2020-191144
[34] Zeng, L. X., Xiao, C. W., Sun, J. Y., Wang, J.J., and Yang, L. (2020).Changes of expression of inflammatory factors and activity of IL-23/IL-17 signaling pathway in patients with chronic hepatitis B. Chinese Journal of Nosocomiology, (10):1512-1516. doi: 10.11816/cn.ni.2020-191552
[35] Qiu, C. M. and Yin, G. L. (2013). Study on the Effects of Squalene Softgel on Enhancing Anoxia Endurance Function. Journal of the Chinese Cereals and Oils Association, 28(02): 52-54. doi:10.3969/j.issn.1003-0174.2013.02.011
[36] Narayan Bhilwade, H., Tatewaki, N., Nishida, H., and Konishi, T. (2010). Squalene as Novel Food Factor. Current Pharmaceutical Biotechnology, 11(8), 875–880. doi: 10.2174/138920110793262088
[37] Farvin, K. H. S., Kumar, S. H. S., Anandan, R., Mathew, S., Sankar, T. V., and Nair, P. G. V. (2007). Supplementation of squalene attenuates experimentally induced myocardial infarction in rats. Food Chemistry, 105(4), 1390–1395. doi: 10.1016/j.foodchem.2007.05.034
[38] Zhu, Y. S., and Chu, J. (2015). Effect and mechanism of glycyrrhizin on atherosclerosis in rats. Guangdong Medical Journal, 36 (3):365-368. doi: 10.13820/j.cnki.gdyx.2015.03.012